A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines
2007

Inducible System for Studying uPAR in Prostate Cancer

publication Evidence: moderate

Author Information

Author(s): Hasanuzzaman Mohammad, Kutner Robert, Agha-Mohammadi Siamak, Reiser Jakob, Sehgal Inder

Primary Institution: Louisiana State University

Hypothesis

Can an inducible lentiviral system effectively express uPAR and study its effects in prostate cancer cell lines?

Conclusion

The doxycycline-inducible lentivirus system successfully produces biologically active uPAR in prostate cancer cells, enhancing their adhesion and resistance to anoikis.

Supporting Evidence

  • Induced uPAR expression led to increased cell adhesion to vitronectin.
  • Prostate cancer cells with induced uPAR showed enhanced proliferation.
  • Cells expressing uPAR were more resistant to anoikis compared to uninduced cells.

Takeaway

This study created a special virus that helps scientists see how a protein called uPAR affects prostate cancer cells, making them stick better and survive longer when they are not attached to anything.

Methodology

The study used a doxycycline-inducible lentiviral vector to express uPAR and DsRed in prostate cancer cell lines, assessing the effects on cell adhesion, proliferation, and resistance to anoikis.

Limitations

The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.

Digital Object Identifier (DOI)

10.1186/1476-4598-6-34

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication